Homepage Slider

World's Top Academic Journal 'Nature-Nano' Features KBS, UL Research

In this Nature Nanotechnology article, Dr Finbarr Murphy and Dr Martin Mullins, KBS, UL join forces with legal, regulatory and underwriting expertise to highlight their approach to the global community.

Nanomaterials promise great advances in material fabrication such as ultra strong, ultra light aeroplane manufacture. In medicine, nanomedicines are being developed as alternatives to biological remedies in the treatment antimicrobial resistance. Engineered nanomaterials are likely to become integral parts of photovoltaics and energy storage devices. The list  goes on, indeed, engineered nanomaterials are already widely used in a variety of products like cosmetics, food packaging and ceramics. For all of this, the extent to which engineered nanomaterials could potentially be harmful for the environment and for humans is not fully understood.

In this article, Dr Murphy, Dr Mullins and co-authors  present the field of nanotechnology from an insurance point of view. The extent to which it is necessary to implement insurance policies specific to nanomaterials is not something often considered by academia or industry. However, the lack of clarity on risks associated specifically to the nanoscale could be seriously detrimental to the development of the nanotechnology-enabled products, and this can only be avoided by more-effective communications between the insurance sectors and researchers. In close conjunction with the insurance industry, KBS, UL researchers have employed actuarial and machine learning tools to assess the risk from the perspective of the underwriter. This approach has been commended by the European Commission and forms part of a number of EU H2020 projects.

Nature Nanotechnology is the foremost journal in Nanotechnology with a 5 year impact factor of 44.3. To read the full paper click here

The research leading to this Commentary has received funding from the European Community’s Horizon 2020 Programme under grant agreement no. 720851, PROTECT (www.protect-h2020.eu).